Cerebrolysin
CERENeuropeptide preparation studied in neuroprotection.
Also known as: FPF-1070
Overview
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids studied in neuroprotection, neuroplasticity, and cognitive research.
A peptide preparation derived from purified porcine brain proteins, containing low-molecular-weight neuropeptides and amino acids with neurotrophic activity mimicking endogenous growth factors. Studied extensively for stroke, dementia, and traumatic brain injury.
Studied for mimicking neurotrophic-factor activity, supporting neuronal survival, plasticity, and repair signaling.
Molecular information
Not a single molecule — a standardized enzymatic hydrolysate of brain proteins.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Neuroprotection research
- Neuroplasticity studies
- Cognitive-recovery investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Course (10–20 days)
Neurotrophic and cognitive changes reported during repeated-course protocols.
Post-course
Effects are proposed to persist between courses in dementia/stroke research.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Dihexa
Complementary neurotrophic/synaptogenic pathways.
P21
Complementary neurogenic mechanisms.
Semax
Distinct nootropic pathway; co-studied in neuro research.
Quality indicators
Clear solution
Supplied as a clear, amber-tinged solution in ampoules; should be particle-free.
Standardized preparation
Verify it is a standardized hydrolysate from a reputable source.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Among the most clinically studied entries here, with large stroke and dementia trial datasets.
- Rare hypersensitivity reactions and injection-site effects are reported.
References & further reading
Cerebrolysin in stroke and dementia (review)
Review of the porcine brain-derived peptide preparation's neurotrophic effects across major neurological trials.
View studyTopics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Substantial peer-reviewed research across multiple models.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue